Medistep Healthcare eyes Rs 16.09 Cr fundraise to acquire new plant & machinery

August 07, 2025 | Thursday | News

To ensure uninterrupted raw material procurement and optimal inventory levels

image credit- shutterstock

image credit- shutterstock

Medistep Healthcare is set to raise approximately Rs 16.09 crore through its upcoming fixed-price Initial Public Offering (IPO), with the primary objective of strengthening its manufacturing infrastructure through the acquisition of advanced plant and machinery.

A significant portion of the IPO proceeds will be allocated toward the acquisition and installation of state-of-the-art equipment at the company’s existing manufacturing facility in Kheda, Gujarat. At the core of this investment is a fully automated, high-speed sanitary pad production line, capable of producing up to 500 pads per minute. This integrated line features raw material feeding, embossing, adhesive application, and inline quality inspection within a single, streamlined workflow.

Additionally, the company will commission a twin‐shaft ribbon blender with vacuum‐sealed hoppers and an integrated volumetric filler from DEF Tech Industries. This system will enable precise and hygienic blending and packaging of energy powder sachets at speeds of up to 200 units per minute. To enhance the secondary packaging process, three modular tri‐axis flow‐wrap machines will also be installed. These machines are equipped for automatic bag feeding, sealing, date-coding, and stacking, thereby increasing throughput and significantly reducing manual processes.

The capital expenditure also covers plant-floor modifications, utility installations, operator training, and warranty support. All systems are expected to be fully operational and certified within three months of their scheduled delivery in Q4 FY26. This strategic infrastructure upgrade is projected to increase overall manufacturing capacity by approximately 30% over the next 12 months, markedly improving production efficiency, product quality, and the company’s responsiveness to growing market demand.

A portion of the funds will also go toward bolstering working capital to ensure uninterrupted raw material procurement and optimal inventory levels. Remaining proceeds will be used for general corporate purposes and expenses related to the IPO. 

Founded in June 2023, Medistep Healthcare has quickly established a pan-India distribution network for a diversified portfolio of pharmaceutical, nutraceutical, surgical, and intimate-care products. The company reported revenue of ₹4,965.48 lakh in FY25, up from ₹3,907.19 lakh in FY24.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy